Literature DB >> 16563687

The stability of the amorphous form of cefuroxime axetil in solid state.

Anna Jelińska1, Izabela Dudzińska, Marianna Zajac, Irena Oszczpowicz.   

Abstract

The stability of the amorphous form of cefuroxime axetil was studied by means of the stress stability test. The degradation was evaluated using the HPLC method with UV detection (278 nm), as described in the monograph of Cefuroxime Axetil in European Pharmacopoeia. Liquid chromatography was performed with a H5 SAS Hypersil column (5 microm particle size, 250 mmx4 mm), the mobile phase consisted of a mixture of 38 volumes of methanol and 62 volumes of a 23 g l-1 solution of ammonium dihydrogen phosphate, a flow rate of 1.2 ml min-1, and the internal standard was a solution of acetanilide in a mixture (1:1) of acetonitrile and water at a concentration of 0.2 mg ml-1. At an increased temperature at RH=0%, the degradation of cefuroxime axetil (CFA) diastereoisomers is the reversible first-order reaction, while that occurring in humid air (RH>25%) is the reversible first-order autocatalytic reaction with Delta3-isomers and E-isomers of cefuroxime axetil and cefuroxime as the main products.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16563687     DOI: 10.1016/j.jpba.2006.02.008

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  3 in total

1.  Formulation of cefuroxime axetil oral suspension and investigation of its pharmaceutical properties.

Authors:  Hadi Valizadeh; Aynoor Farajnia; Parvin Zakeri-Milani
Journal:  Adv Pharm Bull       Date:  2011-12-15

2.  Optimization of a Cefuroxime Axetil-Loaded Liquid Self-Nanoemulsifying Drug Delivery System: Enhanced Solubility, Dissolution and Caco-2 Cell Uptake.

Authors:  Arshad Ali Khan; Akhtar Atiya; Safia Akhtar; Yogesh Yadav; Kamal A Qureshi; Mariusz Jaremko; Syed Mahmood
Journal:  Pharmaceutics       Date:  2022-04-01       Impact factor: 6.525

3.  Assay of Diastereoisomers of Cefuroxime Axetil in Amorphous and Crystalline Forms Using UHPLC-DAD.

Authors:  Piotr Garbacki; Artur Teżyk; Przemysław Zalewski; Anna Jelińska; Magdalena Paczkowska; Alicja Talczyńska; Irena Oszczapowicz; Judyta Cielecka-Piontek
Journal:  Chromatographia       Date:  2014-10-09       Impact factor: 2.044

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.